Phoenix Molecular secures seed funding

Vancouver, British Columbia and San Diego-based Phoenix Molecular, a developer of precise cancer therapeutics targeting essential kinases, has raised US$12 million in seed funding. The investors included Pallasite Ventures and World Changing Ventures.